Report Overview
This report provides a deep insight into the global Tumor Immunity Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Tumor Immunity Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Tumor Immunity Therapy market in any manner.
Global Tumor Immunity Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Bristol-Myers Squibb
Merck & Co., Inc.
Roche AG
AstraZeneca, Plc
Sanofi S.A.
Dendreon Pharmaceuticals
Novartis
Gilead Sciences Inc.
IMVAQ Therapeutics
Arch Oncology
Juno Therapeutics
Refuge
Lepu Biopharma
Genoimmune
TCR Cure
Market Segmentation (by Type)
Immune Checkpoint Inhibitor
Cytokine Immunotherapy
Cancer Vaccine
Car-t Cell Therapy
Others
Market Segmentation (by Application)
Hospital
Clinic
Geographic Segmentation
? North America (USA, Canada, Mexico)
? Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
? Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
? South America (Brazil, Argentina, Columbia, Rest of South America)
? The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
? Industry drivers, restraints, and opportunities covered in the study
? Neutral perspective on the market performance
? Recent industry trends and developments
? Competitive landscape & strategies of key players
? Potential & niche segments and regions exhibiting promising growth covered
? Historical, current, and projected market size, in terms of value
? In-depth analysis of the Tumor Immunity Therapy Market
? Overview of the regional outlook of the Tumor Immunity Therapy Market:
Key Reasons to Buy this Report:
? Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
? This enables you to anticipate market changes to remain ahead of your competitors
? You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
? The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
? Provision of market value (USD Billion) data for each segment and sub-segment
? Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
? Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
? Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
? Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
? The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
? Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
? Provides insight into the market through Value Chain
? Market dynamics scenario, along with growth opportunities of the market in the years to come
? 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Tumor Immunity Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Tumor Immunity Therapy
1.2 Key Market Segments
1.2.1 Tumor Immunity Therapy Segment by Type
1.2.2 Tumor Immunity Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Tumor Immunity Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Tumor Immunity Therapy Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Tumor Immunity Therapy Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Tumor Immunity Therapy Market Competitive Landscape
3.1 Global Tumor Immunity Therapy Sales by Manufacturers (2019-2024)
3.2 Global Tumor Immunity Therapy Revenue Market Share by Manufacturers (2019-2024)
3.3 Tumor Immunity Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Tumor Immunity Therapy Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Tumor Immunity Therapy Sales Sites, Area Served, Product Type
3.6 Tumor Immunity Therapy Market Competitive Situation and Trends
3.6.1 Tumor Immunity Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Tumor Immunity Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Tumor Immunity Therapy Industry Chain Analysis
4.1 Tumor Immunity Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Tumor Immunity Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Tumor Immunity Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Tumor Immunity Therapy Sales Market Share by Type (2019-2024)
6.3 Global Tumor Immunity Therapy Market Size Market Share by Type (2019-2024)
6.4 Global Tumor Immunity Therapy Price by Type (2019-2024)
7 Tumor Immunity Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Tumor Immunity Therapy Market Sales by Application (2019-2024)
7.3 Global Tumor Immunity Therapy Market Size (M USD) by Application (2019-2024)
7.4 Global Tumor Immunity Therapy Sales Growth Rate by Application (2019-2024)
8 Tumor Immunity Therapy Market Segmentation by Region
8.1 Global Tumor Immunity Therapy Sales by Region
8.1.1 Global Tumor Immunity Therapy Sales by Region
8.1.2 Global Tumor Immunity Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Tumor Immunity Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Tumor Immunity Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Tumor Immunity Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Tumor Immunity Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Tumor Immunity Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 Bristol-Myers Squibb
9.1.1 Bristol-Myers Squibb Tumor Immunity Therapy Basic Information
9.1.2 Bristol-Myers Squibb Tumor Immunity Therapy Product Overview
9.1.3 Bristol-Myers Squibb Tumor Immunity Therapy Product Market Performance
9.1.4 Bristol-Myers Squibb Business Overview
9.1.5 Bristol-Myers Squibb Tumor Immunity Therapy SWOT Analysis
9.1.6 Bristol-Myers Squibb Recent Developments
9.2 Merck and Co., Inc.
9.2.1 Merck and Co., Inc. Tumor Immunity Therapy Basic Information
9.2.2 Merck and Co., Inc. Tumor Immunity Therapy Product Overview
9.2.3 Merck and Co., Inc. Tumor Immunity Therapy Product Market Performance
9.2.4 Merck and Co., Inc. Business Overview
9.2.5 Merck and Co., Inc. Tumor Immunity Therapy SWOT Analysis
9.2.6 Merck and Co., Inc. Recent Developments
9.3 Roche AG
9.3.1 Roche AG Tumor Immunity Therapy Basic Information
9.3.2 Roche AG Tumor Immunity Therapy Product Overview
9.3.3 Roche AG Tumor Immunity Therapy Product Market Performance
9.3.4 Roche AG Tumor Immunity Therapy SWOT Analysis
9.3.5 Roche AG Business Overview
9.3.6 Roche AG Recent Developments
9.4 AstraZeneca, Plc
9.4.1 AstraZeneca, Plc Tumor Immunity Therapy Basic Information
9.4.2 AstraZeneca, Plc Tumor Immunity Therapy Product Overview
9.4.3 AstraZeneca, Plc Tumor Immunity Therapy Product Market Performance
9.4.4 AstraZeneca, Plc Business Overview
9.4.5 AstraZeneca, Plc Recent Developments
9.5 Sanofi S.A.
9.5.1 Sanofi S.A. Tumor Immunity Therapy Basic Information
9.5.2 Sanofi S.A. Tumor Immunity Therapy Product Overview
9.5.3 Sanofi S.A. Tumor Immunity Therapy Product Market Performance
9.5.4 Sanofi S.A. Business Overview
9.5.5 Sanofi S.A. Recent Developments
9.6 Dendreon Pharmaceuticals
9.6.1 Dendreon Pharmaceuticals Tumor Immunity Therapy Basic Information
9.6.2 Dendreon Pharmaceuticals Tumor Immunity Therapy Product Overview
9.6.3 Dendreon Pharmaceuticals Tumor Immunity Therapy Product Market Performance
9.6.4 Dendreon Pharmaceuticals Business Overview
9.6.5 Dendreon Pharmaceuticals Recent Developments
9.7 Novartis
9.7.1 Novartis Tumor Immunity Therapy Basic Information
9.7.2 Novartis Tumor Immunity Therapy Product Overview
9.7.3 Novartis Tumor Immunity Therapy Product Market Performance
9.7.4 Novartis Business Overview
9.7.5 Novartis Recent Developments
9.8 Gilead Sciences Inc.
9.8.1 Gilead Sciences Inc. Tumor Immunity Therapy Basic Information
9.8.2 Gilead Sciences Inc. Tumor Immunity Therapy Product Overview
9.8.3 Gilead Sciences Inc. Tumor Immunity Therapy Product Market Performance
9.8.4 Gilead Sciences Inc. Business Overview
9.8.5 Gilead Sciences Inc. Recent Developments
9.9 IMVAQ Therapeutics
9.9.1 IMVAQ Therapeutics Tumor Immunity Therapy Basic Information
9.9.2 IMVAQ Therapeutics Tumor Immunity Therapy Product Overview
9.9.3 IMVAQ Therapeutics Tumor Immunity Therapy Product Market Performance
9.9.4 IMVAQ Therapeutics Business Overview
9.9.5 IMVAQ Therapeutics Recent Developments
9.10 Arch Oncology
9.10.1 Arch Oncology Tumor Immunity Therapy Basic Information
9.10.2 Arch Oncology Tumor Immunity Therapy Product Overview
9.10.3 Arch Oncology Tumor Immunity Therapy Product Market Performance
9.10.4 Arch Oncology Business Overview
9.10.5 Arch Oncology Recent Developments
9.11 Juno Therapeutics
9.11.1 Juno Therapeutics Tumor Immunity Therapy Basic Information
9.11.2 Juno Therapeutics Tumor Immunity Therapy Product Overview
9.11.3 Juno Therapeutics Tumor Immunity Therapy Product Market Performance
9.11.4 Juno Therapeutics Business Overview
9.11.5 Juno Therapeutics Recent Developments
9.12 Refuge
9.12.1 Refuge Tumor Immunity Therapy Basic Information
9.12.2 Refuge Tumor Immunity Therapy Product Overview
9.12.3 Refuge Tumor Immunity Therapy Product Market Performance
9.12.4 Refuge Business Overview
9.12.5 Refuge Recent Developments
9.13 Lepu Biopharma
9.13.1 Lepu Biopharma Tumor Immunity Therapy Basic Information
9.13.2 Lepu Biopharma Tumor Immunity Therapy Product Overview
9.13.3 Lepu Biopharma Tumor Immunity Therapy Product Market Performance
9.13.4 Lepu Biopharma Business Overview
9.13.5 Lepu Biopharma Recent Developments
9.14 Genoimmune
9.14.1 Genoimmune Tumor Immunity Therapy Basic Information
9.14.2 Genoimmune Tumor Immunity Therapy Product Overview
9.14.3 Genoimmune Tumor Immunity Therapy Product Market Performance
9.14.4 Genoimmune Business Overview
9.14.5 Genoimmune Recent Developments
9.15 TCR Cure
9.15.1 TCR Cure Tumor Immunity Therapy Basic Information
9.15.2 TCR Cure Tumor Immunity Therapy Product Overview
9.15.3 TCR Cure Tumor Immunity Therapy Product Market Performance
9.15.4 TCR Cure Business Overview
9.15.5 TCR Cure Recent Developments
10 Tumor Immunity Therapy Market Forecast by Region
10.1 Global Tumor Immunity Therapy Market Size Forecast
10.2 Global Tumor Immunity Therapy Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Tumor Immunity Therapy Market Size Forecast by Country
10.2.3 Asia Pacific Tumor Immunity Therapy Market Size Forecast by Region
10.2.4 South America Tumor Immunity Therapy Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Tumor Immunity Therapy by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Tumor Immunity Therapy Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Tumor Immunity Therapy by Type (2025-2030)
11.1.2 Global Tumor Immunity Therapy Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Tumor Immunity Therapy by Type (2025-2030)
11.2 Global Tumor Immunity Therapy Market Forecast by Application (2025-2030)
11.2.1 Global Tumor Immunity Therapy Sales (Kilotons) Forecast by Application
11.2.2 Global Tumor Immunity Therapy Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Tumor Immunity Therapy Market Size Comparison by Region (M USD)
Table 5. Global Tumor Immunity Therapy Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Tumor Immunity Therapy Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Tumor Immunity Therapy Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Tumor Immunity Therapy Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tumor Immunity Therapy as of 2022)
Table 10. Global Market Tumor Immunity Therapy Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Tumor Immunity Therapy Sales Sites and Area Served
Table 12. Manufacturers Tumor Immunity Therapy Product Type
Table 13. Global Tumor Immunity Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Tumor Immunity Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Tumor Immunity Therapy Market Challenges
Table 22. Global Tumor Immunity Therapy Sales by Type (Kilotons)
Table 23. Global Tumor Immunity Therapy Market Size by Type (M USD)
Table 24. Global Tumor Immunity Therapy Sales (Kilotons) by Type (2019-2024)
Table 25. Global Tumor Immunity Therapy Sales Market Share by Type (2019-2024)
Table 26. Global Tumor Immunity Therapy Market Size (M USD) by Type (2019-2024)
Table 27. Global Tumor Immunity Therapy Market Size Share by Type (2019-2024)
Table 28. Global Tumor Immunity Therapy Price (USD/Ton) by Type (2019-2024)
Table 29. Global Tumor Immunity Therapy Sales (Kilotons) by Application
Table 30. Global Tumor Immunity Therapy Market Size by Application
Table 31. Global Tumor Immunity Therapy Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Tumor Immunity Therapy Sales Market Share by Application (2019-2024)
Table 33. Global Tumor Immunity Therapy Sales by Application (2019-2024) & (M USD)
Table 34. Global Tumor Immunity Therapy Market Share by Application (2019-2024)
Table 35. Global Tumor Immunity Therapy Sales Growth Rate by Application (2019-2024)
Table 36. Global Tumor Immunity Therapy Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Tumor Immunity Therapy Sales Market Share by Region (2019-2024)
Table 38. North America Tumor Immunity Therapy Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Tumor Immunity Therapy Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Tumor Immunity Therapy Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Tumor Immunity Therapy Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Tumor Immunity Therapy Sales by Region (2019-2024) & (Kilotons)
Table 43. Bristol-Myers Squibb Tumor Immunity Therapy Basic Information
Table 44. Bristol-Myers Squibb Tumor Immunity Therapy Product Overview
Table 45. Bristol-Myers Squibb Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Bristol-Myers Squibb Business Overview
Table 47. Bristol-Myers Squibb Tumor Immunity Therapy SWOT Analysis
Table 48. Bristol-Myers Squibb Recent Developments
Table 49. Merck and Co., Inc. Tumor Immunity Therapy Basic Information
Table 50. Merck and Co., Inc. Tumor Immunity Therapy Product Overview
Table 51. Merck and Co., Inc. Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. Merck and Co., Inc. Business Overview
Table 53. Merck and Co., Inc. Tumor Immunity Therapy SWOT Analysis
Table 54. Merck and Co., Inc. Recent Developments
Table 55. Roche AG Tumor Immunity Therapy Basic Information
Table 56. Roche AG Tumor Immunity Therapy Product Overview
Table 57. Roche AG Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Roche AG Tumor Immunity Therapy SWOT Analysis
Table 59. Roche AG Business Overview
Table 60. Roche AG Recent Developments
Table 61. AstraZeneca, Plc Tumor Immunity Therapy Basic Information
Table 62. AstraZeneca, Plc Tumor Immunity Therapy Product Overview
Table 63. AstraZeneca, Plc Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. AstraZeneca, Plc Business Overview
Table 65. AstraZeneca, Plc Recent Developments
Table 66. Sanofi S.A. Tumor Immunity Therapy Basic Information
Table 67. Sanofi S.A. Tumor Immunity Therapy Product Overview
Table 68. Sanofi S.A. Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Sanofi S.A. Business Overview
Table 70. Sanofi S.A. Recent Developments
Table 71. Dendreon Pharmaceuticals Tumor Immunity Therapy Basic Information
Table 72. Dendreon Pharmaceuticals Tumor Immunity Therapy Product Overview
Table 73. Dendreon Pharmaceuticals Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. Dendreon Pharmaceuticals Business Overview
Table 75. Dendreon Pharmaceuticals Recent Developments
Table 76. Novartis Tumor Immunity Therapy Basic Information
Table 77. Novartis Tumor Immunity Therapy Product Overview
Table 78. Novartis Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Novartis Business Overview
Table 80. Novartis Recent Developments
Table 81. Gilead Sciences Inc. Tumor Immunity Therapy Basic Information
Table 82. Gilead Sciences Inc. Tumor Immunity Therapy Product Overview
Table 83. Gilead Sciences Inc. Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Gilead Sciences Inc. Business Overview
Table 85. Gilead Sciences Inc. Recent Developments
Table 86. IMVAQ Therapeutics Tumor Immunity Therapy Basic Information
Table 87. IMVAQ Therapeutics Tumor Immunity Therapy Product Overview
Table 88. IMVAQ Therapeutics Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. IMVAQ Therapeutics Business Overview
Table 90. IMVAQ Therapeutics Recent Developments
Table 91. Arch Oncology Tumor Immunity Therapy Basic Information
Table 92. Arch Oncology Tumor Immunity Therapy Product Overview
Table 93. Arch Oncology Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Arch Oncology Business Overview
Table 95. Arch Oncology Recent Developments
Table 96. Juno Therapeutics Tumor Immunity Therapy Basic Information
Table 97. Juno Therapeutics Tumor Immunity Therapy Product Overview
Table 98. Juno Therapeutics Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Juno Therapeutics Business Overview
Table 100. Juno Therapeutics Recent Developments
Table 101. Refuge Tumor Immunity Therapy Basic Information
Table 102. Refuge Tumor Immunity Therapy Product Overview
Table 103. Refuge Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Refuge Business Overview
Table 105. Refuge Recent Developments
Table 106. Lepu Biopharma Tumor Immunity Therapy Basic Information
Table 107. Lepu Biopharma Tumor Immunity Therapy Product Overview
Table 108. Lepu Biopharma Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 109. Lepu Biopharma Business Overview
Table 110. Lepu Biopharma Recent Developments
Table 111. Genoimmune Tumor Immunity Therapy Basic Information
Table 112. Genoimmune Tumor Immunity Therapy Product Overview
Table 113. Genoimmune Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 114. Genoimmune Business Overview
Table 115. Genoimmune Recent Developments
Table 116. TCR Cure Tumor Immunity Therapy Basic Information
Table 117. TCR Cure Tumor Immunity Therapy Product Overview
Table 118. TCR Cure Tumor Immunity Therapy Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 119. TCR Cure Business Overview
Table 120. TCR Cure Recent Developments
Table 121. Global Tumor Immunity Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 122. Global Tumor Immunity Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 123. North America Tumor Immunity Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 124. North America Tumor Immunity Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 125. Europe Tumor Immunity Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 126. Europe Tumor Immunity Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 127. Asia Pacific Tumor Immunity Therapy Sales Forecast by Region (2025-2030) & (Kilotons)
Table 128. Asia Pacific Tumor Immunity Therapy Market Size Forecast by Region (2025-2030) & (M USD)
Table 129. South America Tumor Immunity Therapy Sales Forecast by Country (2025-2030) & (Kilotons)
Table 130. South America Tumor Immunity Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 131. Middle East and Africa Tumor Immunity Therapy Consumption Forecast by Country (2025-2030) & (Units)
Table 132. Middle East and Africa Tumor Immunity Therapy Market Size Forecast by Country (2025-2030) & (M USD)
Table 133. Global Tumor Immunity Therapy Sales Forecast by Type (2025-2030) & (Kilotons)
Table 134. Global Tumor Immunity Therapy Market Size Forecast by Type (2025-2030) & (M USD)
Table 135. Global Tumor Immunity Therapy Price Forecast by Type (2025-2030) & (USD/Ton)
Table 136. Global Tumor Immunity Therapy Sales (Kilotons) Forecast by Application (2025-2030)
Table 137. Global Tumor Immunity Therapy Market Size Forecast by Application (2025-2030) & (M USD)
List of Figures
Figure 1. Product Picture of Tumor Immunity Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Tumor Immunity Therapy Market Size (M USD), 2019-2030
Figure 5. Global Tumor Immunity Therapy Market Size (M USD) (2019-2030)
Figure 6. Global Tumor Immunity Therapy Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Tumor Immunity Therapy Market Size by Country (M USD)
Figure 11. Tumor Immunity Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Tumor Immunity Therapy Revenue Share by Manufacturers in 2023
Figure 13. Tumor Immunity Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Tumor Immunity Therapy Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Tumor Immunity Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Tumor Immunity Therapy Market Share by Type
Figure 18. Sales Market Share of Tumor Immunity Therapy by Type (2019-2024)
Figure 19. Sales Market Share of Tumor Immunity Therapy by Type in 2023
Figure 20. Market Size Share of Tumor Immunity Therapy by Type (2019-2024)
Figure 21. Market Size Market Share of Tumor Immunity Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Tumor Immunity Therapy Market Share by Application
Figure 24. Global Tumor Immunity Therapy Sales Market Share by Application (2019-2024)
Figure 25. Global Tumor Immunity Therapy Sales Market Share by Application in 2023
Figure 26. Global Tumor Immunity Therapy Market Share by Application (2019-2024)
Figure 27. Global Tumor Immunity Therapy Market Share by Application in 2023
Figure 28. Global Tumor Immunity Therapy Sales Growth Rate by Application (2019-2024)
Figure 29. Global Tumor Immunity Therapy Sales Market Share by Region (2019-2024)
Figure 30. North America Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Tumor Immunity Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Tumor Immunity Therapy Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Tumor Immunity Therapy Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Tumor Immunity Therapy Sales Market Share by Country in 2023
Figure 37. Germany Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Tumor Immunity Therapy Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Tumor Immunity Therapy Sales Market Share by Region in 2023
Figure 44. China Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Tumor Immunity Therapy Sales and Growth Rate (Kilotons)
Figure 50. South America Tumor Immunity Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Tumor Immunity Therapy Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Tumor Immunity Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Tumor Immunity Therapy Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Tumor Immunity Therapy Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Tumor Immunity Therapy Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Tumor Immunity Therapy Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Tumor Immunity Therapy Market Share Forecast by Type (2025-2030)
Figure 65. Global Tumor Immunity Therapy Sales Forecast by Application (2025-2030)
Figure 66. Global Tumor Immunity Therapy Market Share Forecast by Application (2025-2030)
